Holdings of Direxion Daily S&P Biotech Bull 3X Shares
Direxion Shares ETF Trust · Original filing · Compare with another fund · Report an error
- Net assets
- 494.4M $ including 330.9M $ in equities, 66.9 %
- Positions
- 146 in 6 countries
- Top ten
- 9.4 % of net assets
- Filed on
- Jul 31, 2026
Portfolio shape
Positions
| Rank | Company | Shares | Value | Weight |
|---|---|---|---|---|
| 1 | Apogee Therapeutics Inc | 40,796 | 5.5M $ | 1.11 % |
| 2 | ORUKA THERAPEUTICS INC | 52,700 | 5.1M $ | 1.03 % |
| 3 | Dianthus Therapeutics Inc | 44,156 | 4.7M $ | 0.96 % |
| 4 | Erasca Inc | 252,386 | 4.6M $ | 0.93 % |
| 5 | TWIST BIOSCIENCE CORP | 49,791 | 4.6M $ | 0.92 % |
| 6 | KYMERA THERAPEUTICS INC | 43,133 | 4.5M $ | 0.90 % |
| 7 | Spyre Therapeutics Inc | 44,942 | 4.4M $ | 0.89 % |
| 8 | REVOLUTION MEDICINES INC | 23,402 | 4.4M $ | 0.89 % |
| 9 | CG ONCOLOGY INC | 61,441 | 4.4M $ | 0.88 % |
| 10 | Protagonist Therapeutics Inc | 31,902 | 4.4M $ | 0.88 % |
| 11 | Praxis Precision Medicines Inc | 14,020 | 4.3M $ | 0.87 % |
| 12 | Regeneron Pharmaceuticals Inc | 5,608 | 4.3M $ | 0.87 % |
| 13 | COGENT BIOSCIENCES INC | 107,533 | 4.2M $ | 0.85 % |
| 14 | NATERA INC | 15,588 | 4.2M $ | 0.84 % |
| 15 | Arrowhead Pharmaceuticals Inc | 47,707 | 4M $ | 0.82 % |
| 16 | TRAVERE THERAPEUTICS INC | 72,196 | 4M $ | 0.82 % |
| 17 | Roivant Sciences Ltd | 118,777 | 4M $ | 0.81 % |
| 18 | Relay Therapeutics Inc | 213,661 | 4M $ | 0.81 % |
| 19 | MODERNA INC | 73,372 | 4M $ | 0.81 % |
| 20 | VAXCYTE INC | 74,294 | 4M $ | 0.81 % |
| 21 | Bridgebio Pharma Inc | 50,063 | 4M $ | 0.81 % |
| 22 | Halozyme Therapeutics Inc | 47,863 | 4M $ | 0.80 % |
| 23 | Rhythm Pharmaceuticals Inc | 39,370 | 3.9M $ | 0.79 % |
| 24 | CYTOKINETICS INC | 50,312 | 3.9M $ | 0.79 % |
| 25 | Viking Therapeutics Inc | 121,599 | 3.9M $ | 0.78 % |
| 26 | Amgen Inc | 9,994 | 3.8M $ | 0.78 % |
| 27 | Incyte Corp | 32,018 | 3.8M $ | 0.77 % |
| 28 | MIRUM PHARMACEUTICALS INC | 35,899 | 3.8M $ | 0.77 % |
| 29 | Alkermes PLC | 76,970 | 3.8M $ | 0.76 % |
| 30 | TG THERAPEUTICS INC | 72,380 | 3.8M $ | 0.76 % |
| 31 | AbbVie Inc | 15,001 | 3.8M $ | 0.76 % |
| 32 | Vertex Pharmaceuticals Inc | 7,744 | 3.7M $ | 0.75 % |
| 33 | Krystal Biotech Inc | 10,801 | 3.7M $ | 0.75 % |
| 34 | Insmed Inc | 36,726 | 3.6M $ | 0.73 % |
| 35 | Scholar Rock Holding Corp | 76,534 | 3.6M $ | 0.73 % |
| 36 | Gilead Sciences Inc | 27,780 | 3.6M $ | 0.73 % |
| 37 | BioMarin Pharmaceutical Inc | 60,076 | 3.6M $ | 0.73 % |
| 38 | uniQure NV | 81,217 | 3.5M $ | 0.72 % |
| 39 | DYNE THERAPEUTICS INC | 140,706 | 3.5M $ | 0.72 % |
| 40 | Biogen Inc | 17,370 | 3.5M $ | 0.71 % |
| 41 | Neurocrine Biosciences Inc | 20,978 | 3.5M $ | 0.71 % |
| 42 | ACADIA Pharmaceuticals Inc | 134,777 | 3.5M $ | 0.71 % |
| 43 | Exelixis Inc | 64,176 | 3.4M $ | 0.69 % |
| 44 | IMMUNOVANT INC | 87,318 | 3.4M $ | 0.68 % |
| 45 | Madrigal Pharmaceuticals Inc | 7,159 | 3.3M $ | 0.68 % |
| 46 | GRAIL Inc | 48,308 | 3.3M $ | 0.67 % |
| 47 | Celcuity Inc | 38,241 | 3.3M $ | 0.67 % |
| 48 | Summit Therapeutics Inc | 252,586 | 3.3M $ | 0.67 % |
| 49 | CRISPR Therapeutics AG | 68,253 | 3.3M $ | 0.66 % |
| 50 | United Therapeutics Corp | 6,202 | 3.2M $ | 0.65 % |
| 51 | PTC Therapeutics Inc | 46,006 | 3.1M $ | 0.63 % |
| 52 | Ultragenyx Pharmaceutical Inc | 124,269 | 3.1M $ | 0.63 % |
| 53 | IMMUNITYBIO INC | 423,471 | 3M $ | 0.61 % |
| 54 | SELLAS Life Sciences Group Inc | 293,250 | 2.9M $ | 0.59 % |
| 55 | Beam Therapeutics Inc | 114,427 | 2.9M $ | 0.59 % |
| 56 | BioCryst Pharmaceuticals Inc | 324,702 | 2.9M $ | 0.59 % |
| 57 | VERA THERAPEUTICS INC | 89,811 | 2.9M $ | 0.58 % |
| 58 | Ideaya Biosciences Inc | 78,418 | 2.8M $ | 0.56 % |
| 59 | Denali Therapeutics Inc | 117,771 | 2.7M $ | 0.55 % |
| 60 | Tango Therapeutics Inc | 97,971 | 2.7M $ | 0.54 % |
| 61 | Arcutis Biotherapeutics Inc | 98,745 | 2.7M $ | 0.54 % |
| 62 | Celldex Therapeutics Inc | 68,644 | 2.6M $ | 0.53 % |
| 63 | VIRIDIAN THERAPEUTICS INC | 132,937 | 2.5M $ | 0.51 % |
| 64 | Disc Medicine Inc | 32,477 | 2.5M $ | 0.51 % |
| 65 | ARCUS BIOSCIENCES INC | 87,676 | 2.5M $ | 0.50 % |
| 66 | Mineralys Therapeutics Inc | 95,578 | 2.4M $ | 0.49 % |
| 67 | IONIS PHARMACEUTICALS INC | 46,023 | 2.4M $ | 0.48 % |
| 68 | ALNYLAM PHARMACEUTICALS INC | 11,586 | 2.4M $ | 0.48 % |
| 69 | Veracyte Inc | 50,707 | 2.3M $ | 0.48 % |
| 70 | Immunome Inc | 101,669 | 2.3M $ | 0.47 % |
| 71 | Syndax Pharmaceuticals Inc | 119,538 | 2.3M $ | 0.46 % |
| 72 | Recursion Pharmaceuticals Inc | 750,099 | 2.3M $ | 0.46 % |
| 73 | SAREPTA THERAPEUTICS INC | 151,157 | 2.2M $ | 0.45 % |
| 74 | ADMA Biologics Inc | 264,044 | 2.2M $ | 0.45 % |
| 75 | Kodiak Sciences Inc | 50,808 | 2.1M $ | 0.43 % |
| 76 | Intellia Therapeutics Inc | 195,077 | 2.1M $ | 0.42 % |
| 77 | Agios Pharmaceuticals Inc | 67,945 | 2M $ | 0.41 % |
| 78 | Iovance Biotherapeutics Inc | 492,493 | 2M $ | 0.41 % |
| 79 | Nurix Therapeutics Inc | 83,566 | 1.9M $ | 0.39 % |
| 80 | PALVELLA THERAPEUTICS INC | 13,887 | 1.9M $ | 0.39 % |
| 81 | Novavax Inc | 255,116 | 1.9M $ | 0.38 % |
| 82 | Vericel Corp | 40,581 | 1.9M $ | 0.38 % |
| 83 | Biohaven Ltd | 128,814 | 1.7M $ | 0.35 % |
| 84 | CareDx Inc | 38,851 | 1.7M $ | 0.34 % |
| 85 | Stoke Therapeutics Inc | 53,472 | 1.5M $ | 0.31 % |
| 86 | Precigen Inc | 240,763 | 1.5M $ | 0.31 % |
| 87 | TYRA BIOSCIENCES INC | 47,312 | 1.5M $ | 0.31 % |
| 88 | Vir Biotechnology Inc | 168,048 | 1.5M $ | 0.29 % |
| 89 | ZENAS BIOPHARMA INC | 45,855 | 1.4M $ | 0.29 % |
| 90 | AnaptysBio Inc | 26,728 | 1.4M $ | 0.29 % |
| 91 | First Tracks Biotherapeutics Inc | 31,615 | 1.4M $ | 0.28 % |
| 92 | Absci Corp | 175,722 | 1.4M $ | 0.28 % |
| 93 | Hyperliquid Strategies Inc | 215,077 | 1.3M $ | 0.27 % |
| 94 | Cullinan Therapeutics Inc | 80,791 | 1.3M $ | 0.27 % |
| 95 | Xencor Inc | 65,912 | 1.3M $ | 0.27 % |
| 96 | Corvus Pharmaceuticals Inc | 99,617 | 1.3M $ | 0.27 % |
| 97 | VOR BIOPHARMA INC | 59,675 | 1.3M $ | 0.26 % |
| 98 | AVALO THERAPEUTICS INC | 68,958 | 1.3M $ | 0.25 % |
| 99 | Ardelyx Inc | 252,024 | 1.2M $ | 0.25 % |
| 100 | ORIC Pharmaceuticals Inc | 110,953 | 1.2M $ | 0.25 % |
Sector breakdown
- Health care 14.0 %
- Unattributed 86.0 %
Titelia assigns each company to a sector, one by one. The unassigned share stays visible, under "Unattributed".
Currency breakdown
- USD 100.0 %
Each line is counted in its quoted currency, as the fund declares it.
Country breakdown
- United States 94.9 %
- Ireland 1.3 %
- Bermuda 1.2 %
- Netherlands 1.1 %
- Switzerland 1.0 %
- British Virgin Islands 0.5 %
Shares are computed on the fund's equities only.
| Rank | Country | Lines | Value | Share |
|---|---|---|---|---|
| 1 | United States | 140 | 314.1M $ | 94.94 % |
| 2 | Ireland | 2 | 4.2M $ | 1.26 % |
| 3 | Bermuda | 1 | 4M $ | 1.22 % |
| 4 | Netherlands | 1 | 3.5M $ | 1.07 % |
| 5 | Switzerland | 1 | 3.3M $ | 0.99 % |
| 6 | British Virgin Islands | 1 | 1.7M $ | 0.53 % |
Cite this page
Titelia. "Holdings of Direxion Daily S&P Biotech Bull 3X Shares". https://titelia.com/en/funds/S000049373